Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells

Journal of Rheumatology

Volumn 26, Issue 4, 1999, Pages 785-790

  Kumon, Yoshitaka ^a   Suehiro, Tadashi ^b   Hashimoto, Kozo ^b   Nakatani, Ko ^b   Sipe, Jean D ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Osteoarthritis; Rheumatoid Arthritis; SAA Isoforms; Synovial Fluid; Synovium

Indexed keywords

SERUM AMYLOID A;

ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM;

AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; BLOTTING, NORTHERN; CELLS, CULTURED; DEXAMETHASONE; DNA PRIMERS; DRUG INTERACTIONS; HUMANS; INTERLEUKIN-1; MOLECULAR SEQUENCE DATA; OSTEOARTHRITIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; SYNOVIAL FLUID; UP-REGULATION;

EID: 0032916193     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive proteins, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-8.
2. McAdam KPWJ, Elin RJ, Sipe JD, Wolff SM. Changes in human serum amyloid A and C-reaclive protein following etiocholanolone-induced inflammation. J Clin Invest 1978;61:390-4.
3. Sukenik S, Henkin J, Ziinlichman S, et al. Serum and synovial fluid levels of serum amyloid A protein C-reactive protein in inflammatory and noninflammatory arthritis. J Rheumatol 1988;15:942-5.
4. Loose LD, Sipe JD, Kirby DS, et al. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug. Br J Rheumatol 1993;32 Suppl 3:19-25.
5. Kumon Y, Loose LD, Birbara CA, Sipe JD. Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein. J Rheumatol 1997;24:14-9.
6. Whitehead AS, de Beer MC, Steel DM, et al. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992;267:3862-7.
7. de Beer MC, Beach CM, Shedlofsky SI, de Beer FC. Identification of a novel serum amyloid A protein (SAA) in BALB/c mice. Biochem J 1991;280:45-9.
8. Liepnieks JJ, Dwulet FE, Benson MD, Kluve-Beckerman B, Kushner I. The primary structure of serum amyloid A protein in the rabbit: comparison with serum amyloid A proteins in other species. J Lab Clin Med 1991;118:570-5.
9. Meek RL, Ericksen N, Benditt EP. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci USA 1992;89:7949-52.
10. Mitchell TI, Coon CI, Brinckerhoff CE. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J Clin Invest 1991;87:1177-85.
11. Kumon Y, Sipe JD, Brinckerhoff CE, Schreiber BM. Regulation of extrahepatic apolipoprotein serum amyloid A (apoSAA) gene expression by interleukin 1-a alone: Synthesis and secretion of apoSAA by cultured aortic smooth muscle cells. Scand J Immunol 1997;46:284-91.
12. Kluve-Beckerman B, Drumm ML, Benson MD. Non-expression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol 1991;10:651-61.
13. Pruzanski W, de Beer FC, de Beer MC, Stefanski E, Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem J 1995;309:461-4.
14. Badolato R, Wang JM, Murphy WJ, et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorpnonuclear leukocytes. J Exp Med 1994;180:203-9.
15. Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci Lett 1997;225:73-6.
16. Altman R, Asch E, Bloch G, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
17. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Kikumoto Y, Hong YM, Nishida T, Nakai S, Masui Y, Hirai Y. Purification and characterization of recombinant human interleukin-1b produced in Escherichia coli. Biochem Biophys Res Commun 1987;147:315-21.
19. Sipe JD, Colten HR, Boldberger G, et al. Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry 1985;24:2931-6.
20. Kluve-Beckerman B, Long GL, Benson MD. DNA sequence evidence for polymorphic forms of human serum amyloid A. Biochem Genet 1986;24:795-803.
21. Tokunaga K, Nakamura Y, Sakaka K, et al. Enhanced expression of a glyceride-3-phosphate dehydrogenase gene in human lung cancer. Cancer Res 1987;47:5616-9.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual: extraction, purification, and analysis of messenger RNA from eukaryotic cells. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989:7.3-7.83.
23. Rokita H, Loose LD, Bartle LM, Sipe JD. Synergism of interleukin-1 and interleukin 6 induces serum amyloid production while depressing fibrogen: a quantitative analysis. J Rheumatol 1994;21:400-5.
24. Steel DM, Donoghue FC, O'Neill RM, Uhlar CM, Whitehead AS. Expression and regulation of constitutive and acute phase serum amyloid A mRNA in hepatic and non-hepatic cell lines. Scand J Immunol 1996;44:493-500.
25. Farahat MN, Yannig K, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993:52:870-5.
26. Simkin PA. Synovial perfusion and synovial fluid solutes. Ann Rheum Dis 1995;54:424-8.
27. Brinckerhoff CE, Michell TI, Karmilowicz MJ, Kluve-Beckerman B, Benson MD. Autocrine induction of collagenase by serum amyloid A-like and b2-microglobulin-like proteins. Science 1989;243:655-7.
28. Mitchell TI, Jeffrey JJ, Palmiter RD, Brinckerhoff CE. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim Biophys Acta 1993;1156:245-54.
29. Pruzanski W, Scott K, Smith G, Rajkovic I, Stefanski E, Vadas P. Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids. Inflammation 1992;16:451-7.
30. Gatter RA. Arthrocentesis technique and intrasynovial therapy. In: McCarty DJ, editor. Arthritis and allied conditions. Philadelphia: Lea & Febiger; 1989:646-56.
31. Ostergaad M, Stoltenberg M, Gideon P, Sorensen K, Henriksen O, Lorenzen I. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol 1996;23:1151-61.
32. Roberts WN, Babcock EA, Breitbach SA, Owen DS, Irby WR. Corticosteroid injection in rheumatoid arthritis does not increase rate of total joint arthroplasty. J Rheumatol 1996:23:1001-4.